Baytacare Pharmaceutical Co., Ltd. reported audited consolidated earnings results for the year ended December 31, 2017. For the year, the company reported revenue of RMB 17,080,000 compared to RMB 29,480,000 a year ago. Loss before income tax expense was RMB 88,420,000 compared to profit before income tax expense of RMB 129,000 a year ago. Loss for the year attributable to owners of the company was RMB 73,596,000 or 8.58 cent per basic share compared to profit of RMB 255,000 or 0.03 cent per basic share a year ago. Net cash used in operating activities was RMB 19,491,000 compared to RMB 44,088,000 a year ago. Acquisition of intangible assets was RMB 71,000 compared with RMB 166,000 a year ago. Acquisition of property, plant and equipment was RMB 423,000 compared with RMB 1,533,000 a year ago.